{"id":904655,"date":"2025-11-03T18:40:24","date_gmt":"2025-11-03T23:40:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/"},"modified":"2025-11-03T18:40:24","modified_gmt":"2025-11-03T23:40:24","slug":"beta-bionics-announces-participation-at-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/","title":{"rendered":"Beta Bionics Announces Participation at Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>IRVINE, Calif., Nov.  03, 2025  (GLOBE NEWSWIRE) &#8212; Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at two upcoming investor conferences (all Eastern Time):<\/p>\n<ul type=\"disc\">\n<li>Wolfe Research 7<sup>th<\/sup> Annual Healthcare Conference on Tuesday, November 18, 2025 at 2:00pm<\/li>\n<li>Piper Sandler 37<sup>th<\/sup> Annual Healthcare Conference on Tuesday, December 2, 2025 at 4:30pm\n<\/li>\n<\/ul>\n<p>The presentations will be webcast live. The link to the webcasts will be available on the Company\u2019s website in the \u201cInvestors\u2014Events &amp; Presentations\u201d section at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9vifQknZlUUnJWuK1NyJEQbx9AUidp0jS4MR-qKN9_2wcLYbDMRx9IOAoywdtRF75UCNZdiNPuVTiz1X57eKY3Ei55NaiOEATwEV8SqjzM3Th5pIpQgtqvlqdhbjnqbL\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.betabionics.com<\/a>, and will be archived there for future replay following the events.<\/p>\n<p>\n        <strong>About Beta Bionics<\/strong>\n      <\/p>\n<p>Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mSdBZPniqbIJT01SHXWX1ILK6u3W8QdyD0ERSPcsYCyptxOsocQJv361RgYBiRaHN7r4XGjsZeUSJZYz1qjFtNH1mesbyoRYzbvImMO6JOg=\" rel=\"nofollow\" target=\"_blank\">www.betabionics.com<\/a>.<\/p>\n<p>\n        <strong>Investor Relations:<\/strong><br \/>\n        <br \/>Blake Beber<br \/>Head of Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-HQzBxYq-ZdzjZK5gRggsK4aZE0hUcRmp8u6KrfKg8TuJFvE6w3rYRR54A5YO44ZkVY5sqIaox2d8EjpR90IA5f0W-77NT5ceISJknLx9Fc=\" rel=\"nofollow\" target=\"_blank\"><strong>ir@betabionics.com<\/strong><\/a><\/p>\n<p>\n        <strong>Media and Public Relations<\/strong>: <br \/>Karen Hynes<br \/>Vice President of Marketing<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=laf53EYjx_EUyjoIw2jTbiAc5ov3jI0kTvAzlN3MyfjCMkfXrB51gNUbF_ZwEgT8MAgn3QUABHXAKytIrXuFSMFKxLe9B6tJAqCUK60hch4=\" rel=\"nofollow\" target=\"_blank\"><strong>media@betabionics.com<\/strong><\/a><\/p>\n<p>Source:\u00a0Beta Bionics, Inc.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzY5NSM3MjQxMzY2IzIyMDczOTY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTliZjgyMjktY2FlZi00OWJjLWE2NGYtZmQ0MDIzNTAzY2QxLTEyMTg5NDktMjAyNS0xMS0wMy1lbg==\/tiny\/Beta-Bionics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>IRVINE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at two upcoming investor conferences (all Eastern Time): Wolfe Research 7th Annual Healthcare Conference on Tuesday, November 18, 2025 at 2:00pm Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 4:30pm The presentations will be webcast live. The link to the webcasts will be available on the Company\u2019s website in the \u201cInvestors\u2014Events &amp; Presentations\u201d section at https:\/\/investors.betabionics.com, and will be archived there for future replay following the events. About Beta Bionics Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Beta Bionics Announces Participation at Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-904655","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Beta Bionics Announces Participation at Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Beta Bionics Announces Participation at Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at two upcoming investor conferences (all Eastern Time): Wolfe Research 7th Annual Healthcare Conference on Tuesday, November 18, 2025 at 2:00pm Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 4:30pm The presentations will be webcast live. The link to the webcasts will be available on the Company\u2019s website in the \u201cInvestors\u2014Events &amp; Presentations\u201d section at https:\/\/investors.betabionics.com, and will be archived there for future replay following the events. About Beta Bionics Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization &hellip; Continue reading &quot;Beta Bionics Announces Participation at Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-03T23:40:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzY5NSM3MjQxMzY2IzIyMDczOTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-announces-participation-at-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-announces-participation-at-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Beta Bionics Announces Participation at Upcoming Investor Conferences\",\"datePublished\":\"2025-11-03T23:40:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-announces-participation-at-upcoming-investor-conferences\\\/\"},\"wordCount\":223,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-announces-participation-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzY5NSM3MjQxMzY2IzIyMDczOTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-announces-participation-at-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-announces-participation-at-upcoming-investor-conferences\\\/\",\"name\":\"Beta Bionics Announces Participation at Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-announces-participation-at-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-announces-participation-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzY5NSM3MjQxMzY2IzIyMDczOTY=\",\"datePublished\":\"2025-11-03T23:40:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-announces-participation-at-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-announces-participation-at-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-announces-participation-at-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzY5NSM3MjQxMzY2IzIyMDczOTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzY5NSM3MjQxMzY2IzIyMDczOTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-announces-participation-at-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Beta Bionics Announces Participation at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Beta Bionics Announces Participation at Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Beta Bionics Announces Participation at Upcoming Investor Conferences - Market Newsdesk","og_description":"IRVINE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at two upcoming investor conferences (all Eastern Time): Wolfe Research 7th Annual Healthcare Conference on Tuesday, November 18, 2025 at 2:00pm Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 4:30pm The presentations will be webcast live. The link to the webcasts will be available on the Company\u2019s website in the \u201cInvestors\u2014Events &amp; Presentations\u201d section at https:\/\/investors.betabionics.com, and will be archived there for future replay following the events. About Beta Bionics Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization &hellip; Continue reading \"Beta Bionics Announces Participation at Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-03T23:40:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzY5NSM3MjQxMzY2IzIyMDczOTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Beta Bionics Announces Participation at Upcoming Investor Conferences","datePublished":"2025-11-03T23:40:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/"},"wordCount":223,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzY5NSM3MjQxMzY2IzIyMDczOTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/","name":"Beta Bionics Announces Participation at Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzY5NSM3MjQxMzY2IzIyMDczOTY=","datePublished":"2025-11-03T23:40:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzY5NSM3MjQxMzY2IzIyMDczOTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzY5NSM3MjQxMzY2IzIyMDczOTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-announces-participation-at-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Beta Bionics Announces Participation at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=904655"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904655\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=904655"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=904655"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=904655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}